SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS is sinking after second-quarter results missed and full-year guidance was slashed, with management citing a highly promotional athletic footwear market and a weaker Foot Locker business. The community is split between dip buyers calling it an overreaction and bears expecting further downside, while broader retail weakness, tariff risk, and consumer strain dominate the conversation.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is getting hammered after its earnings showed revenue growth and raised guidance but also wider losses, weak margins, and convertible-debt concerns; bulls are calling the selloff overdone, pointing to contracted AI infrastructure upside and unannounced wins, while bears focus on dilution and profitability.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

LULU is drawing heavy chatter as Michael Burry and BlackRock disclosed fresh buying while the stock gets caught in athletic-retail sympathy selling after Dick's Sporting Goods' weak guidance. Bulls frame it as a deep-value/short-squeeze setup ahead of earnings and the new CEO's start, while bears point to consumer weakness, Canada tariff exposure, and rising Alo/Vuori competition.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical metals names are ripping as speculation over U.S.-China trade tensions and the Western mine-to-magnet push ignites the sector, with CEO Sage's media appearances and Tanbreez progress feeding the bullish frenzy. Traders are buzzing about a potential short squeeze and the upcoming EUR merger, though some still debate the company's published NPV accuracy.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is moving on sympathy with Dick's Sporting Goods' weaker outlook, sparking debate over whether the swoosh is a bargain or a value trap as traders weigh brand struggles, tariffs, and shifting consumer demand.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

The announcement of Navitas' acquisition of Claros to expand its AI data-center power delivery technology is dominating discussion, with the community split between bullish views on the expanded market opportunity and bearish concerns over dilution and the sharp post-announcement price drop.

Greenland Mines Ltd. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Charlotte, NC.

Greenland Mines Ltd.

GRML is buzzing after its completed 1-for-50 reverse split collided with a newly released independent assessment for the Sarfartoq rare earth project, which bulls see as confirmation of world-class critical-minerals potential in a hot sector. Community chatter is split between low-float momentum and a freshly refreshed ATM equity line, with bulls focusing on rare-earth upside while bears warn of post-split dilution overhang.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Reddit is buzzing about a potential short squeeze in this biotech, driven by a hefty jump in short interest against a backdrop of institutional accumulation and a highly anticipated upcoming NEXICART-2 data readout. The community is laser-focused on the potential for a massive upside move as they believe the fundamentally sound science, backed by high complete response rates, will force shorts to cover.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is surging through a key psychological barrier as the U.S. Treasury's bond-buyback-driven liquidity push and heavy ETF inflows reignite the debasement trade, fueling a short squeeze. The community remains fiercely split: bulls call this a fresh bull cycle and a return of the macro uptrend, while skeptical bears dismiss it as an overheated pump or a bull trap.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following an FDA decision to extend the PDUFA target date to November 22, 2026, as the agency reviews a major BLA amendment focused on upper-limb function. Investors are closely monitoring the company's refined path to approval, while community sentiment remains split between bullish hopes for a squeeze and skepticism regarding regulatory challenges.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS Don’t under estimate the desperation a patent cliff creates in big pharma.Just as the CEO of Merck how he will approach a $30+B gap in his income statement when Keytruda patent runs out! Acquisitions in this space is not if but when and who.

Dan flint

Fausto Rossi

Jerry Springer

mz101

BOB BEE

Fritz Franz

Jay Glenn

Andy L.

James

John-Mark

Jeremy Dworkin

상후니

Arturas Paulikas

Thor

Longnstrongdong

Walt

Adam Roberts

Ulaughing

Bill Day

Sven

nick

Charles ford

Steve call

Stephen

StockTwits for iOS

SELLAS Life Sciences Group Inc

 Don’t under estimate the desperation a patent cliff creates in big pharma.Just as the CEO of Merck how he will approach a $30+B gap in his income statement when Keytruda patent runs out! Acquisitions in this space is not if but when and who.

Gray Wolf

@graywolf I think the number will be fantastic, but they have to wait on data. They can’t afford a kirflunckle just before a cliff.

 I think the number will be fantastic, but they have to wait on data. They can’t afford a kirflunckle just before a cliff.

Robert Ham

@graywolf I would hate to be Mrk ceo if JNJ or LLY put down a big offer before data release. Talk about squeezing hemorrhoids!

 I would hate to be Mrk ceo if JNJ or LLY put down a big offer before data release. Talk about squeezing hemorrhoids!

@Fivgardnks yes 80th plus data. I would even leave the approval and dealing with FDA to the acquiring Big Pharma

 yes 80th plus data. I would even leave the approval and dealing with FDA to the acquiring Big Pharma

@graywolf i just hope the number is so big, a stock swap is the only way. Make it easier to make it to long term holding .

 i just hope the number is so big, a stock swap is the only way. Make it easier to make it to long term holding .